Moreover, CHX chase assays demonstrated that Trim21 overexpression promoted CCT2 protein degradation in breast cancer cells (Fig. 4E), whereas Trim21 knockdown extended the half-life of the CCT2 protein (supplementary Fig. 5F). This evidence concerns the gene CCT2 and breast cancer.